Sumitomo Chemical Co., Ltd. TSE:4005

Sumitomo Chemical : Summary of Consolidated Financial Results for First Quarter Fiscal Year 2026

Published

Source: MarketScreener

Key Figures of Consolidated Financial Results for 1st Quarter FY2026

August 4, 2026 Sumitomo Chemical Co., Ltd.
  1. Financial Summary (IFRS) (Billions of yen)

    Q1 FY2026

    Q1 FY2025

    Variance

    FY2026

    (Forecast

    announced in May)

    FY2025

    Sales revenue

    578.2

    526.1

    52.1

    2,360.0

    2,328.5

    Core operating income

    62.3

    27.7

    34.7

    215.0

    208.4

    Operating income

    61.0

    25.5

    35.6

    177.0

    151.7

    Net income (loss) attributable to

    owners of the parent

    40.8

    (4.5)

    45.3

    70.0

    60.9

    Basic earnings (loss) per share

    ¥ 24.70

    ¥ (2.76)

    ¥ 27.46

    ¥ 42.40

    ¥ 37.16

    Return on equity

    3.9%

    (0.5)%

    4.4%

    6.8%

    6.4%

    Exchange rate (yen/$)

    159.57

    144.59

    -

    155.00

    150.67

    Naphtha price (yen/kl)

    118,500

    66,300

    -

    92,000

    65,200

    *Core operating income is a gain and loss concept that reflects recurring earning capacity by deducting gains and losses incurred by non-recurring factors from operating income, which includes the share of profits or losses from investments accounted for using the equity method.

  2. Sales Revenue / Core Operating Income by Reporting Segment (IFRS) (Billions of yen)

    Q1 FY2026

    Q1 FY2025 Variance

    FY2026

    (Forecast FY2025

    announced in May)

    Agro & Life Solutions

    Sales revenue

    109.0

    96.9

    12.1

    560.0

    519.3

    Core operating

    income

    9.6

    2.2

    7.4

    65.0

    56.3

    ICT & Mobility Solutions

    Sales revenue

    148.6

    137.4

    11.2

    590.0

    574.2

    Core operating

    income

    13.0

    18.4

    (5.3)

    55.0

    53.0

    Advanced Medical Solutions

    Sales revenue

    10.4

    9.1

    1.4

    60.0

    58.6

    Core operating

    income

    (1.9)

    (1.0)

    (0.9)

    3.0

    2.8

    Essential & Green Materials

    Sales revenue

    170.2

    165.4

    4.8

    560.0

    678.8

    Core operating

    income

    27.2

    (5.5)

    32.7

    20.0

    14.4

    Sumitomo Pharma

    Sales revenue

    129.0

    107.4

    21.6

    540.0

    451.9

    Core operating

    income

    18.8

    21.0

    (2.2)

    94.0

    108.4

    Others

    Sales revenue

    11.0

    10.0

    1.0

    50.0

    45.8

    Core operating

    income

    3.1

    1.8

    1.3

    4.0

    4.4

    Adjustments

    Sales revenue

    -

    -

    -

    -

    -

    Core operating

    income

    (7.5)

    (9.2)

    1.7

    (26.0)

    (31.1)

    Total

    Sales revenue

    578.2

    526.1

    52.1

    2,360.0

    2,328.5

    Core operating

    income

    62.3

    27.7

    34.7

    215.0

    208.4

  3. Summary of Consolidated Statement of Income (IFRS)

    (Billions of yen)

    Q1 FY2026

    Q1 FY2025

    Variance

    Variance

    Ratio

    Sales revenue

    578.2

    526.1

    52.1

    9.9%

    Core operating income

    62.3

    27.7

    34.7

    125.2%

    of which equity-method investments

    12.2

    (9.8)

    22.0

    -

    Total non-recurring items (breakdown below)

    (1.3)

    (1.1)

    (0.2)

    (2.2)

    0.9

    -

    Restructuring costs

    Others

    (2.7)

    0.5

    1.7

    (0.7)

    -

    -

    Operating income

    61.0

    25.5

    35.6

    139.8%

    Finance income/expenses (breakdown below)

    (0.7)

    (19.6)

    18.9

    -

    Gain (loss) on foreign currency transactions including gain (loss) on derivatives

    1.6

    (16.4)

    (18.0)

    -

    Others

    (2.3)

    (3.3)

    (0.9)

    -

    Income before taxes

    60.3

    5.8

    54.5

    936.8%

    Income tax expenses

    (9.0)

    (1.9)

    (7.0)

    -

    Net income

    51.4

    3.9

    47.5

    -

    Net (income) attributable to non-controlling interests

    (10.6)

    (8.4)

    (2.2)

    -

    Net income (loss) attributable to owners of the parent

    40.8

    (4.5)

    45.3

    -

    ROE

    3.9%

    (0.5)%

    Exchange rate (yen/$)

    159.57

    144.59

    Naphtha price (yen/kl)

    118,500

    66,300

    Overseas sales revenue ratio

    67.7%

    68.5%

  4. Summary of Consolidated Statement of Financial Position (IFRS)

    (Billions of yen)

    30-June-26

    31-Mar-26 Variance

    30-June-26

    31-Mar-26 Variance

    Current Assets

    1,659.1

    1,507.7

    151.3

    Liabilities

    2,201.1

    2,168.4

    32.7

    Cash and cash

    equivalents

    223.2

    208.6

    14.6

    Trade and other payables

    550.1

    464.4

    85.7

    Trade and other

    receivables

    644.5

    608.7

    35.9

    Interest-bearing liabilities

    1,132.2

    1,151.5

    (19.3)

    Inventories

    643.6

    595.5

    48.1

    Others

    518.8

    552.5

    (33.7)

    Others

    147.7

    95.0

    52.7

    Equity

    1,412.4

    1,236.7

    175.8

    Non-current assets

    1,954.4

    1,897.3

    57.1

    Shareholders' equity

    807.9

    744.9

    63.1

    Property, plant and

    equipment

    777.6

    770.7

    6.9

    Other components of

    equity

    294.9

    263.8

    31.2

    Goodwill and intangible

    assets

    502.5

    501.0

    1.5

    Non-controlling interests

    309.6

    228.0

    81.6

    Others

    674.4

    625.6

    48.8

    Total

    3,613.5

    3,405.0

    208.5

    Total

    3,613.5

    3,405.0

    208.5

    Ratio of equity attributable to

    owners of the parent to total assets

    30.5%

    29.6%

    0.9%

    D/E ratio (times)

    0.80

    0.93

    (0.13)

  5. Summary of Consolidated Statement of Cash Flows (IFRS)

(Billions of yen)

Q1 FY2026

Q1 FY2025 Variance

FY2025

Cash flows from operating activities

5.0

24.0

(19.0)

234.8

Cash flows from investing activities

(49.2)

(45.9)

(3.3)

(74.8)

Free cash flows

(44.3)

(21.9)

(22.3)

159.9

Cash flows from financing activities

55.6

(49.2)

104.8

(199.1)

Others

3.3

(0.9)

4.2

15.7

Increase (decrease) in cash and cash equivalents

14.6

(72.1)

86.7

(23.5)

Cash and cash equivalents at the end of the period

223.2

142.6

80.6

208.6

Note: This document has been translated from the Japanese-language original (hereinafter, the "original") for reference purposes only. In the event of any discrepancy between this translated document and the original, the original shall prevail. The original of Quarterly Consolidated Financial Statements has undergone a review by the Company's audit firm. Please refer to the Japanese review report for details.



August 4, 2026

Summary of Consolidated Financial Results for First Quarter Fiscal Year 2026 (Under IFRS)

Company name: Sumitomo Chemical Co., Ltd. Listing: Tokyo Stock Exchange Securities code: 4005

URL: https://www.sumitomo-chem.co.jp/english/ Representative: Nobuaki Mito, Representative Director & President

Inquiries: Shoko Wato, General Manager, Corporate Communications Dept. Telephone: +81-3-5201-0200

Scheduled date to commence dividend payments: －

Preparation of supplementary material on financial results: Yes

Holding of financial results briefing: Yes (for institutional investors and analysts)

(All amounts are rounded to the nearest million yen.)

  1. Consolidated Financial Results for First Quarter Fiscal Year 2026 (April 1, 2026 to June 30, 2026)
    1. Consolidated Operating Results (Percentages indicate year-on-year changes.)

      Sales revenue

      Core operating income

      Operating income

      Net income

      Net income attributable to owners of the parent

      Total comprehensive income

      Millions of yen

      %

      Millions of yen

      %

      Millions of yen

      %

      Millions of yen

      %

      Millions of yen

      %

      -

      -

      Millions of yen

      %

      Q1 FY2026

      578,199

      9.9

      62,336

      125.2

      61,041

      139.8

      51,350

      -

      40,782

      91,645

      -

      Q1 FY2025

      526,140

      (14.0)

      27,681

      388.2

      25,452

      121.3

      3,873

      (88.6)

      (4,523)

      1,125

      (98.4)

      Basic earnings per share

      Diluted earnings per share

      Yen

      Yen

      Q1 FY2026

      24.70

      24.70

      Q1 FY2025

      (2.76)

      -

      Reference: Share of profit (loss) of investments accounted for using the equity method

      Q1 FY2026: ¥ 12,216 million Q1 FY2025: ¥ (9,826) million Income before taxes

      Q1 FY2026: ¥ 60,313 million Q1 FY2025: ¥ 5,817 million

      *Core operating income is a gain and loss concept that reflects recurring earning capacity by deducting gains and losses incurred by non-recurring factors from operating income, which includes the share of profits or losses from investments accounted for using the equity method.

      *For diluted earnings per share for Q1 FY2025, although there are potential shares, they are not listed because they have an anti-dilutive effect.

    2. Consolidated Financial Position

    Total assets

    Total equity

    Equity attributable to owners of the parent

    Ratio of equity attributable to owners of the parent to total assets

    As of

    Millions of yen

    Millions of yen

    Millions of yen

    %

    June 30, 2026

    3,613,506

    1,412,442

    1,102,863

    30.5

    March 31, 2026

    3,405,041

    1,236,673

    1,008,644

    29.6

  2. Dividends

    Dividends per share

    1st quarter end

    2nd quarter end

    3rd quarter end

    Year-end

    Annual

    FY2025 FY2026

    Yen

    -

    -

    Yen

    6.00

    Yen

    -

    Yen

    7.50

    Yen

    13.50

    FY2026 (Forecast)

    8.00

    -

    8.00

    16.00

    Note: Revision of dividend forecasts from the latest announcement: None

  3. Consolidated Financial Forecasts for Fiscal Year 2026
(April 1, 2026 to March 31, 2027) (Percentages indicate year-on-year changes.)

Sales revenue

Core operating income

Operating income

Net income attributable to owners of the parent

Basic earnings per share

Millions of yen

%

Millions of yen

%

Millions of yen

%

Millions of yen

%

Yen

First-half of FY2026

1,170,000

6.8

125,000

15.0

122,000

17.7

70,000

76.3

42.40

Full-year of FY2026

2,360,000

1.4

215,000

3.2

177,000

16.6

70,000

14.9

42.40

Note: Revision of financial forecasts from the latest announcement: None

We now announce the consolidated financial forecast for the first-half of FY2026 as above, which was not announced in the "Summary of Consolidated Financial Results for Fiscal Year 2025 (Under IFRS)" disclosed on May 14, 2026. There are no changes to the consolidated financial forecast for FY2026.

Notes:

  1. Significant changes in the scope of consolidation during the period: None Newly included: －

    Excluded: －

  2. Changes in accounting policies and changes in accounting estimates

    1. Changes in accounting policies required by IFRS: Yes

    2. Changes in accounting policies due to other reasons: None

    3. Changes in accounting estimates: None

  3. Number of shares issued (common shares)

    1. Total number of shares issued at the end of the period (including treasury shares)

      As of June 30, 2026

      1,657,914,399 shares

      As of March 31, 2026

      1,657,914,399 shares

    2. Number of treasury shares at the end of the period

      As of June 30, 2026

      6,503,408 shares

      As of March 31, 2026

      6,500,914 shares

    3. Average number of shares outstanding during the period

Three Months ended June 30, 2026

1,651,217,003 shares

Three Months ended June 30, 2025

1,636,496,435 shares

*Review of the Japanese-language original of the attached quarterly consolidated financial statements by certified public accountants or an audit firm: Yes (voluntary)

*Notes regarding the appropriate use of forecasts and other special items:

Descriptions regarding forward-looking statements about the future performance of the Company contained in this summary are based on information currently available to the Company and certain assumptions judged reasonable and involve risks and uncertainties. The important factors that could cause actual results to differ materially from those discussed in the forward-looking statements include, but are not limited to, general economic conditions in the Company's markets; demand for, and competitive pricing pressure on, the Company's products in the marketplace; rise in prices of raw materials; and fluctuations in foreign exchange rates.